Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of MD Pharma is 0.7% (low). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
2 mandates
2
active directors
Aquitania BVBADirectorMD CONSULTDirector
All directors & mandates Publicationslatest 29-04-2026
12
publications in the State Gazette3 directors appointed, 2 resigningAll publications & acts Network & structure
9
connected companiesSee network & structure
Connections
9 connected companiesParent · 3 subsidiaries · 1 location
Control→
Trust signals
3 signalsMore than 3 years active
Founded in 2016 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.7%
Low
0%0,5%1,5%4%10%≥25%
Higher-failure-rate sector
+Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht77400Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht77400
Primary activity highlighted.
Names & trade names
| Legal nameNL | MD Pharma |
Registered office
Kortrijksesteenweg 1091 bus B
9051 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.